Css LLC Bio N Tech Se Transaction History

Css LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$118.43 - $186.05 $59,215 - $93,025	500 New	500 $75,000
Q1 2022 May 16, 2022	SELL	$126.25 - $231.85 $209,827 - $385,334	-1,662 Reduced 76.87%	500 $85,000
Q4 2021 Feb 14, 2022	BUY	$216.64 - $362.52 $13,215 - $22,113	61 Added 2.9%	2,162 $557,000
Q3 2021 Nov 15, 2021	BUY	$205.93 - $447.23 $168,450 - $365,834	818 Added 63.76%	2,101 $573,000
Q2 2021 Aug 16, 2021	BUY	$113.32 - $241.49 $20,737 - $44,192	183 Added 16.64%	1,283 $287,000

Q1 2021 May 17, 2021	BUY	$85.73 - $119.5 $94,303 - $131,450	1,100 New	1,100 $121,000
Q4 2020 Feb 16, 2021	SELL	$72.71 - $129.54 $743,605 - $1.32 Million	-10,227 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$57.81 - $104.17 $198,057 - $356,886	3,426 Added 50.37%	10,227 $708,000
Q2 2020 Aug 14, 2020	BUY	$38.58 - $66.74 $262,382 - $453,898	6,801 New	6,801 $454,000

327

40.4M

1.31M

1.37M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $19.4B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.